24 /100
LOW RISK
Score updated May 29, 2026

CTNM — Contineum Therapeutics, Inc. Dilution Risk Tracker

Track CTNM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CTNM — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
9%
💰 Capital Raise 18%
• Active ATM program with $100M remaining capacity
🔔 Track CTNM — Get forecast alerts →

💹 Market Data

Market Cap$497.61M
Shares Outstanding32.72M
Float27.59M
Cash$246.33M
Debt$6.95M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 69.2% shares (2025Q4 vs prior)
80 institutional holders · 29.91M shares
#1 SUVRETTA CAPITAL MANAGEMENT, LLC 2.84M shares
#2 JANUS HENDERSON GROUP PLC 2.45M shares
#3 RA CAPITAL MANAGEMENT, L.P. 2.18M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.61M
Days to Cover6.7
% of Float5.8%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2024
424B5 ATM Mar 05, 2026
8-K 8K EVENT Mar 05, 2026
4 INSIDER TRANSACTION Mar 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track CTNM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CTNM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for CTNM
📊 CTNM FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CTNM Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.